Cutera, Inc. (NASDAQ:CUTR)

CAPS Rating: 3 out of 5

Designs, develops, manufactures and markets the CoolGlide, Xeo and Solera product platforms for use by dermatologists, plastic surgeons, gynecologists and other qualified practitioners to offer safe, effective and non-invasive aesthetic treatments.

Recs

1
Player Avatar vcbthornton (68.81) Submitted: 10/17/2006 5:56:08 PM : Outperform Start Price: $26.21 CUTR Score: -75.77

CUTR had been a consistent performer until it was sued for patent infringement by PMTI. It has now settled that suit and should resume its growth.
CUTR is in a good position to profit from the aging of the baby boomers. It offers cosmetic improvements that are less invasive and expensive than cosmetic surgery.

Featured Broker Partners


Advertisement